
Asthma
Buy asthma treatments online, specifically Omalizumab, to effectively manage severe allergic asthma and other related conditions.
Omalizumab is a monoclonal antibody that targets and inhibits IgE antibodies, reducing the frequency and severity of allergic reactions. This advanced medication provides a vital option for patients whose asthma is not adequately controlled by standard treatments.
We Bring the Best Solutions to You. Register Now
Join us in discovering the perfect medical and aesthetic solutions for your clinic. By registering, you'll receive personalized consultations that connect you with an extensive selection of products– tailored to your clinic's distinctive needs and aspirations.
What Diseases Does Omalizumab Treat?
Omalizumab is a versatile medication used to treat several allergic conditions. The primary diseases it addresses include:- Allergic Asthma: Particularly in patients with moderate to severe persistent asthma that is not well managed with inhaled corticosteroids. It helps reduce the frequency of asthma attacks and improves overall respiratory function.
- Chronic Rhinosinusitis with Nasal Polyps (CRSwNP): Omalizumab reduces nasal congestion and the size of polyps in patients who do not respond adequately to nasal corticosteroids.
- Chronic Spontaneous Urticaria (CSU): This condition involves chronic hives without a known cause, and Omalizumab helps manage the symptoms when antihistamines are not effective.
- Food Allergies: Omalizumab can reduce the severity of allergic reactions in individuals with food allergies, although it is not a substitute for emergency treatments or dietary restrictions.
Omalizumab as Asthma Treatment
Omalizumab has proven to be a significant advancement in the treatment of allergic asthma. It works by binding to IgE antibodies, preventing them from attaching to mast cells and basophils, which are involved in allergic reactions. This mechanism helps to reduce inflammation and the subsequent asthma symptoms. For patients with severe allergic asthma, Omalizumab can decrease the number of asthma exacerbations, reduce reliance on corticosteroids, and improve overall lung function. Regular use of Omalizumab can lead to better asthma control, fewer hospital visits, and an enhanced quality of life for patients.Omalizumab Indications and Dosage
Omalizumab is indicated for the following conditions and patient groups:- Allergic Asthma: For adults and children aged 6 and older with moderate to severe persistent asthma not controlled by inhaled corticosteroids. Dosing is based on serum IgE levels and body weight, typically administered every 2 to 4 weeks.
- Chronic Rhinosinusitis with Nasal Polyps (CRSwNP): For adults aged 18 and older who have not responded to nasal corticosteroids. The dose and frequency depend on the patient’s IgE levels and body weight.
- Chronic Spontaneous Urticaria (CSU): For patients aged 12 and older who have hives that are not controlled by H1 antihistamines. The standard dose is 150 to 300 mg every 4 weeks.
- Food Allergies: For individuals aged 1 and older to help reduce the severity of allergic reactions due to accidental exposure to allergens. The dosing regimen is determined based on the patient's specific needs.
Omalizumab Side Effects and Allergic Reactions
While Omalizumab is generally well-tolerated, it can cause side effects in some patients. Common side effects include:- Injection Site Reactions: Redness, swelling, pain, or itching at the site of injection.
- Headache: Particularly in patients with CRSwNP and CSU.
- Joint Pain: Especially in the arms and legs.
- Dizziness: Patients may experience lightheadedness or faintness.
- Upper Respiratory Tract Infections: Symptoms such as cough and sore throat.
- Anaphylaxis: A severe allergic reaction that can occur immediately or days after the injection. Symptoms include wheezing, shortness of breath, chest tightness, and swelling of the throat or tongue.
- Cancer: Rare cases of cancer have been reported in patients using Omalizumab.
- Cardiovascular Issues: Such as chest pain, heart attack, and blood clots.